Cerus Corporation
CERS
#7707
Rank
NZ$0.82 B
Marketcap
NZ$4.10
Share price
0.88%
Change (1 day)
40.33%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): NZ$2.07 Million

According to Cerus Corporation's latest financial reports the company's current earnings are NZ$0.22 Billion. In 2025 the company made an earning of -NZ$12.37 Million, an increase over its 2024 earnings that were of -NZ$21.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$2.07 M-116.77%
2025 -NZ$12.37 Million-41.58%
2024 -NZ$21.17 Million-58.95%
2023 -NZ$51.56 Million-20.74%
2022 -NZ$65.05 Million-25.7%
2021 -NZ$87.55 Million-11.99%
2020 -NZ$99.47 Million-14%
2019 -NZ$0.12 Billion21.73%
2018 -NZ$95.02 Million-0.65%
2017 -NZ$95.64 Million-10.96%
2016 -NZ$0.11 Billion4.24%
2015 -NZ$0.11 Billion50.99%
2014 -NZ$68.25 Million-10.08%
2013 -NZ$75.9 Million184.13%
2012 -NZ$26.72 Million-7.91%
2011 -NZ$29.01 Million
2009 -NZ$40.97 Million-24.69%
2008 -NZ$54.4 Million-25.2%
2007 -NZ$72.73 Million330.54%
2006 -NZ$16.9 Million1.49%
2005 -NZ$16.65 Million-61.02%
2004 -NZ$42.7 Million
2002 -NZ$0.11 Billion10.02%
2001 -NZ$96 Million34.25%
2000 -NZ$71.51 Million61.02%
1999 -NZ$44.41 Million-18.81%
1998 -NZ$54.7 Million93.08%
1997 -NZ$28.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.66 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
NZ$22.95 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.28 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$29.44 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA